您现在的位置: 首页> 研究主题> 皮内试验

皮内试验

皮内试验的相关文献在1982年到2023年内共计369篇,主要集中在临床医学、内科学、药学 等领域,其中期刊论文355篇、会议论文8篇、专利文献368845篇;相关期刊214种,包括护士进修杂志、齐鲁护理杂志、中国临床护理等; 相关会议6种,包括中华医学会2006年全国儿童过敏性疾病诊断与治疗进展研讨会、2006第六届中国药学会学术年会、全国过敏性疾病诊断与治疗进展研讨会等;皮内试验的相关文献由875位作者贡献,包括王良录、尹佳、岳凤敏等。

皮内试验—发文量

期刊论文>

论文:355 占比:0.10%

会议论文>

论文:8 占比:0.00%

专利文献>

论文:368845 占比:99.90%

总计:369208篇

皮内试验—发文趋势图

皮内试验

-研究学者

  • 王良录
  • 尹佳
  • 岳凤敏
  • 关凯
  • 孙劲旅
  • 李宏
  • 王瑞琦
  • 顾建青
  • 文利平
  • 程璇
  • 期刊论文
  • 会议论文
  • 专利文献

搜索

排序:

年份

    • 摘要: 一、皮试皮试是皮肤试验的简称。皮肤试验通常包括点刺试验和皮内试验,目前国内抗菌药物皮肤试验常规采用皮内试验。二、皮试的必要性主要是通过检测,看患儿体内是否有针对该类药物及其代谢、降解产物的特异性IgE抗体,预测发生Ⅰ型(速发型)过敏反应的可能性,降低发生过敏性休克等严重过敏反应风险。预测Ⅱ、Ⅲ、Ⅳ型过敏反应不是皮试的目的,皮试也无法检测药品中是否含有杂质成分。
    • 薛凤霞; 张长皓; 向莉; 申昆玲
    • 摘要: 目前,免疫球蛋白E (immunoglobulin E,IgE)的致敏性检测是诊断过敏性疾病的基础,也是管理过敏性疾病(包括过敏原规避、药物治疗及特异性免疫治疗)的关键。2020年,世界过敏组织(World Allergy Organization,WAO)发表了关于IgE介导过敏反应诊断方法(包括体内检测和体外检测)的立场文件。本文旨在解读该文件中的体内检测部分,详细介绍了皮肤点刺试验(skin prick test,SPT)和皮内试验(intradermal test,IDT)的适应证、技术操作要求、结果判定和解读,比较了两种皮肤试验的优缺点,并对个别问题进行了补充说明,以便于理解。
    • 薛凤霞; 张长皓; 向莉; 申昆玲
    • 摘要: 目前,免疫球蛋白E(immunoglobulin E,IgE)的致敏性检测是诊断过敏性疾病的基础,也是管理过敏性疾病(包括过敏原规避、药物治疗及特异性免疫治疗)的关键.2020年,世界过敏组织(World Allergy Organization,WAO)发表了关于IgE介导过敏反应诊断方法(包括体内检测和体外检测)的立场文件.本文旨在解读该文件中的体内检测部分,详细介绍了皮肤点刺试验(skin prick test,SPT)和皮内试验(intradermal test,IDT)的适应证、技术操作要求、结果判定和解读,比较了两种皮肤试验的优缺点,并对个别问题进行了补充说明,以便于理解.
    • 摘要: 目的:探讨青霉素类抗生素过敏的预测方法、效果及临床用药选择.方法:选择2018年1月至2019年1月本院收治的拟使用青霉素类抗生素治疗的92例患者,随机分为对照组和观察组,各46例.对照组患者采用皮内试验进行青霉素类抗生素过敏预测,观察组患者先进行快速斑贴试验,阴性者再进行皮内试验,统计两组患者青霉素类抗生素敏感性试验阳性率.结果:观察组青霉素钠皮试液快速斑贴试验联合青霉素类抗生素皮内试验检测(32.61%)阳性率高于对照组皮内试验(21.73%),差异具有统计学意义(P=0.022,x2 =4.325).结论:青霉素钠皮试液快速斑贴试验联合皮内试验对青霉素类抗生素过敏预测准确性较高,不易出现漏诊情况,有助于进一步提高青霉素类抗生素的使用安全性,值得推广借鉴.
    • 林志强; 王灿明; 洪珊珊; 吴娜梅
    • 摘要: 目的 回顾性探讨皮内试验(皮试)对头孢曲松钠过敏反应的预测价值. 方法 采用随机等距抽样法,抽取2013年11月至2015年6月在福建医科大学附属泉州第一医院使用头孢曲松钠前进行皮试患者的病历资料进行回顾性分析.根据皮试结果,将患者分为皮试阳性组与皮试阴性组,分析皮试阳性组患者的用药情况,分析皮试阴性组使用头孢曲松钠后出现过敏反应患者的年龄、过敏反应发生时间、临床表现和转归.根据Poisson分布原理,计算皮试阴性组使用头孢曲松钠后过敏反应发生率与假设的不进行皮试使用头孢曲松钠出现过敏反应发生率间的差异. 结果 纳入分析的患者共943例,皮试阳性组30例(3.18%),皮试阴性组913例(96.82%).皮试阳性组患者均未再进行阳性与阴性对照试验及激发试验,在此后治疗中分别使用头孢哌酮钠舒巴坦钠、头孢唑肟、阿奇霉素、左氧氟沙星、阿莫西林舒巴坦、替考拉宁和莫西沙星,均未发生过敏反应.皮试阴性组913例患者在使用头孢曲松钠过程中有10例(1.10%)出现过敏反应,过敏反应发生率为1.10%.发生过敏反应的10例患者中男性、女性各5例,年龄10个月~52岁,≤10岁者6例;4例过敏反应发生在用药后20 min内,6例在用药后4~10 d.主要症状为皮疹和瘙痒,停药及对症处理后好转.皮试阴性组头孢曲松钠过敏反应发生率(1.10%)与假设的应用头孢曲松钠前不进行皮试过敏反应发生率(1%)间的差异无统计学意义(u=0.288,P=0.77). 结论 使用头孢曲松钠前进行常规皮试阴性者未显著降低过敏反应的发生率,提示皮试对头孢曲松钠过敏反应无明显的预测价值.%Objective To explore the predictive value of intradermal test on anaphylaxis induced by ceftriaxone sodium retrospectively. Methods Medical records of patients who underwent intradermal test before ceftriaxone sodium treatment in the First Hospital of Quanzhou Affiliated to Fujian Medical University from November 2013 to June 2015 were collected with random equidistant sampling and analyzed retrospectively. The patients were divided into the positive intradermal test group and the negative intradermal test group according to the results of intradermal test. The situation of medication in patients in the positive intradermal test group and the ages,onset time of anaphylaxis,clinical manifestations,and outcomes in patients with allergic reactions after ceftriaxone sodium treatment in the negative intradermal test group were analyzed,respectively. The difference between the incidence of anaphylactic reactions after ceftriaxone sodium treatment in the negative intradermal test group and the hypothetical incidence of anaphylactic reactions after ceftriaxone sodium treatment without intradermal test were calculated according to Poisson distribution principle. Results A total of 943 patients were enrolled in the study,including 30 patients (3.18%)in the positive intradermal test group and 913 patients (96.82%)in the negative intradermal test group. Neither the positive and negative control tests nor the provocative tests were performed in patients in the positive intradermal test group and no allergic reactions appeared in these patients in the following treatments with cefoperazone sodium and sulbactam sodium, ceftizoxime, azithromycin, levofloxacin, amoxicillin sulbactam, teicoplanin, and moxifloxacin, respectively. Ten (1.1%)of 913 patients in the negative intradermal test group developed anaphylaxis during the use of ceftriaxone sodium,the incidence of anaphylactic reaction was 1.10%,in whom male and female were 5 respectively,aged 10 months to 52 years,6 patients were 10 years old. Of the 10 patients with anaphylactic reactions,4 developed within 20 minutes and 6 developed 4 to 10 days,respectively after the administration. The main symptoms were rash and pruritus,which improved after drug withdrawal and symptomatic treatments. There were no significant difference (u=0.288,P=0.77)between the incidence of anaphylactic reactions in the negative intradermal test group (1.1%)and the hypothetical incidence of ceftriaxone sodium-induced anaphylactic reactions without intradermal test (1.0%). Conclusion The incidence of anaphylaxis did not decrease significantly in patients with negative intradermal test,suggesting that the intradermal test has no obvious value to predict the occurrence of ceftriaxone sodium-induced anaphylaxis.
    • 李宏; 岳凤敏; 徐涛; 程璇; 尹佳; 王瑞琦; 王良录; 孙劲旅; 文利平; 顾建青; 关凯
    • 摘要: 目的 应用圆柏花粉变应原注射原液1:100稀释液进行皮内试验,评价其诊断圆柏花粉过敏的临床应用价值和安全性.方法 回顾性分析2009年2月至7月北京协和医院1043例门诊患者皮内试验结果,将用圆柏花粉变应原注射原液1:100稀释液进行皮内试验的结果分别与变态反应专科医师临床综合诊断及Thermo Fisher公司Immuno CAP系统血清特异性IgE(specific IgE,sIgE)检测结果进行对比,分别计算用皮内试验诊断圆柏花粉过敏的特异度和灵敏度,以及其与变态反应专科医师临床综合诊断和血清sIgE检测结果的一致性.同时记录圆柏花粉变应原注射原液1:100稀释液用于皮内试验的不良反应.结果 以变态反应专科医师临床综合诊断为金标准,以皮内试验结果≥(+)为诊断界值时,圆柏花粉变应原注射原液1:100稀释液皮内试验的灵敏度为0.9574,特异度为0.7145,阳性预测值为0.4018,阴性预测值为0.9882,准确度为0.7550;ROC曲线下面积为0.891,95%可信区间为(0.864,0.918).以Uni-CAP sIgE诊断为金标准,以皮内试验结果≥(+)为诊断界值时,皮内试验的灵敏度为0.9549,特异度为0.1505,阳性预测值为0.6165,阴性预测值为0.7000,准确度为0.6239.与圆柏花粉变应原注射原液1:100稀释液皮内试验有关的全身不良反应1例,属轻度,占0.0959%.结论 使用圆柏花粉变应原注射原液1:100稀释液进行皮内试验,可以安全有效地诊断圆柏花粉变应原引起的过敏性疾病.%Objective To evaluate the accuracy and safety of Sabina chinensis pollen extract which was used for intradermal test ( IDT) in the diagnosis of Sabina chinensis pollen allergy .Methods 1043 Patients were collected and reviewed from Department of Allergy , Peking Union Medical College Hospital since 2009 Feb to 2009 Jul.All patients were prescribed IDT with Sabina chinensis pollen extract and sIgE detection of Juniperus sabinoides ( t6, UniCAP , Phadia ) .The IDT results were recorded and clinical integrated diagnosis was made by allergists .The accuracy of IDT with Sabina chinensis pollen ex-tract was evaluated by using clinical integrated diagnoses of allergists and sIgE detection results as golden standards respectively .Adverse reactions were also recorded for the evaluation of safety .Results IDT results≥ (+) was defined as the cutoff threshold for diagnosing .Sensitivity , specificity , positive predictive value , negative predictive value , accuracy , and area under ROC curve , were 0.9574 , 0.7145, 0.4018, 0.9882, 0.7550 and 0.891, 95%confidence interval (0.864, 0.918) respective-ly by using clinical integrated diagnoses of allergists as gold standard .Whereas sIgE results ≥0.35 kUA/L was defined as the cutoff threshold for diagnosing , sensitivity , specificity , positive predictive value , nega-tive predictive value, and accuracy were 0.9549, 0.1505, 0.6165, 0.7000, and 0.6239 respective-ly.Only 1 (0.0959%) case was attacked by type Ⅰmild systemic adverse reaction during IDT with Sa-bina chinensis pollen extract .Conclusion IDT with Sabina chinensis pollen extract is an accuracy and safe tool for the diagnosis of Sabina chinensis pollen allergy .
    • 王瑞琦; 王良录; 李宏; 孙劲旅; 利平; 顾建青; 关凯; 尹佳
    • 摘要: 目的:评价应用链格孢(Alternaria alternata)变应原注射原液1∶100稀释液进行皮内试验诊断链格孢变态反应的临床应用价值及安全性。方法回顾性分析2009年4月至2010年8月北京协和医院1043例门诊患者皮内试验结果,将链格孢变应原注射原液1∶100稀释液皮内试验结果分别与变态反应专科医生临床综合诊断及Thermo Fisher公司Immuno CAP®系统血清特异性IgE(specific IgE,sIgE)检测结果进行对比,分别计算皮内试验诊断链格孢变态反应的特异度和灵敏度,以及与变态反应专科医生临床综合诊断和血清sIgE检测结果的一致性。同时记录链格孢变应原注射原液1∶100稀释液用于皮内试验的不良反应。结果以变态反应专科医生临床综合诊断作为金标准,以皮内试验结果≥“+”作为诊断界值,链格孢变应原注射原液1∶100稀释液皮内试验灵敏度为0.8864,特异度为0.8945,阳性预测值为0.5000,阴性预测值为0.9851,准确度为0.8936;ROC曲线下面积为0.915,95%可信区间为0.874~0.956。以血清sIgE检测结果作为评价标准,以皮内试验结果≥“+”作为诊断界值,链格孢变应原注射原液1∶100稀释液皮内试验的灵敏度为0.9277,特异度为0.5313,阳性预测值为0.7196,阴性预测值为0.8500,准确度为0.7551。链格孢血清sIgE阳性组中,血清sIgE水平与链格孢变应原注射原液1∶100稀释液的阳性反应程度的等级相关系数为0.62800(P<0.0001)。1043例受试者中,与链格孢变应原皮内试验有关的局部不良反应发生率为0.48%(5/1043),未发现与链格孢变应原有关的全身不良反应。结论使用链格孢变应原注射原液1∶100稀释液进行皮内试验,可以安全、有效地诊断链格孢引起的变态反应性疾病。%Objective To evaluate the accuracy and safety of Alternaria alternata extract which was used for intradermal test in the diagnosis of Alternaria alternata allergy.Methods 1 043 patients who had been prescribed both intradermal skin tests (IDT)and serum specific IgE (sIgE).Detections were collected and reviewed from Department of Allergy,PUMC hospital since Apr.10th to Aug.10th 2009.The accuracy of IDT with Alternaria alternata extract was evaluated byusing clinical diagnoses of allergists and sIgE detection results as golden standards and relative golder standard respectively.Adverse reactions were also recorded.Results IDT results ≥ “+”was defined as the cutoff threshold for diagnosing.Sensitivity,specificity, positive predictive value,negative predictive value,accuracy and area under ROC curve was 0.886 4,0.894 5,0.500 0,0.985 1,0.893 6,0.915 (95% confidence interval 0.874,0.956)respectively by using clinical diagnoses of allergists as gold standard.Whereas sIgE results ≥ 0.35 KUA/L was defined as the cutoff threshold for diagnosing,sensitivity,specificity,positive predictive value,negative predictive value and accuracy was 0.927 7,0.531 3,0.719 6,0.850 0 and 0.755 1 respectively by using sIgE results as standard.Coefficient of rank correlation between sIgE and IDT results was 0.628 00(P <0.000 1) in serum sIgE positive group.Local adverse reactions were recorded in 0.48% (5 /1 043)patients,none of them was attacked by type Ⅰ systemic adverse reaction.Conclusion IDT with Alternaria alternata extract is anaccuracy and safe tool for the diagnosis of Alternaria alternata allergy.
    • 郭华
    • 摘要: 目的 探索破伤风抗毒素不同皮内实验方法 的效果, 以提高患者的就医感受, 减轻其痛苦, 提高护理人员工作效率.方法 1350例因创伤就诊, 需要注射破伤风抗毒素(TAT)的患者, 随机分为对照组(670例)和实验组(680例).实验组采用本院新引进的华康牌YLM-Ⅱ型快速过敏皮试仪进行TAT皮试.对照组按照基础护理教材(第3版)教科书上的TAT皮试方法 进行.使用后对两组阳性率进行比较.结果 对照组和实验组TAT皮试阳性率分别为22.69%(152/670)和11.91(81/680), 两组比较差异有统计学意义(χ2=27.436,P<0.05).结论 采用华康牌YLM-Ⅱ型快速过敏皮试仪进行TAT皮试, 对皮肤无损伤, 皮试实验时间只需要5 min;操作中患者恐惧感和疼痛感减少, 易于接受.
    • 徐德琴1; 徐学君1; 彭国宇1; 盛永丽2
    • 摘要: 破伤风抗毒素(tetanus antitoxin)是由破伤风类毒素免疫马所得的血浆,经胃酶消化后纯化制成的液体抗毒素球蛋白制剂,临床主要用于破伤风的预防和治疗。破伤风抗毒素对人体是一种异体蛋白,具有抗原性,进入人体后刺激机体产生特异性抗体,使机体处于致敏状态,相同的抗原再次进入致敏的机体与产生的特异性抗体结合,
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号